The best indicator for DaVita (DVA)
We backtested 20 indicators across daily, weekly and hourly charts on real DaVita (DVA) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
ADX / DMI
On the weekly chart, this is the strongest risk-adjusted edge we found for DaVita (DVA) over ~30.7 years — trailing buy-and-hold by 1.4% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | ADX / DMI ✓ | Weekly | 12.0% | 0.6 | -51.1% | 51.3% | 39 | -1.4% |
| 2 | RSI Trend (>50) ✓ | Weekly | 10.6% | 0.52 | -50.9% | 44.6% | 74 | -2.9% |
| 3 | EMA 50/200 Cross ✓ | Daily | 9.9% | 0.5 | -49.8% | 40.9% | 22 | -3.6% |
| 4 | EMA 20/50 Cross ✓ | Daily | 8.8% | 0.46 | -61.6% | 40.6% | 64 | -4.6% |
| 5 | Donchian Midline ✓ | Weekly | 9.3% | 0.46 | -65.2% | 42.9% | 77 | -4.1% |
| 6 | Holy Grail Confluence ✓ | Daily | 8.1% | 0.45 | -67.5% | 75.0% | 52 | -5.3% |
| 7 | Bollinger Mean-Reversion ✓ | Weekly | 7.6% | 0.43 | -53.0% | 82.1% | 28 | -5.9% |
| 8 | Bollinger Breakout ✓ | Weekly | 6.9% | 0.42 | -42.0% | 51.7% | 29 | -6.5% |
| 9 | Rate of Change ✓ | Weekly | 8.1% | 0.42 | -65.5% | 42.5% | 87 | -5.4% |
| 10 | SMA 50/200 Cross ✓ | Daily | 7.6% | 0.41 | -56.0% | 41.7% | 24 | -5.9% |
| 11 | EMA-10 Trend ✓ | Daily | 7.5% | 0.4 | -61.6% | 38.8% | 691 | -5.9% |
| 12 | Rate of Change ✓ | Daily | 6.8% | 0.38 | -68.3% | 38.3% | 483 | -6.7% |
| 13 | Stochastic ✓ | Daily | 6.1% | 0.37 | -75.8% | 76.3% | 152 | -7.4% |
| 14 | Money Flow Index ✓ | Daily | 6.5% | 0.37 | -74.1% | 76.7% | 30 | -6.9% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For DaVita (DVA), ADX / DMI on the weekly timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.